Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare – financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. That said, here is one stock where Wall Street’s pessimism is creating a buying opportunity and two facing legitimate challenges.
Two Stocks to Sell:
Macy’s (M)
Consensus Price Target: $21.50 (-14.2% implied return)
With a storied history that began with its 1858 founding, Macy’s (NYSE:M) is a department store chain that sells clothing, cosmetics, accessories, and home goods.
Why Do We Steer Clear of M?
-
Recent store closures and weak same-store sales point to soft demand and an operational restructuring
-
Poor same-store sales performance over the past two years indicates it’s having trouble bringing new shoppers into its brick-and-mortar locations
-
Earnings per share have dipped by 17.8% annually over the past three years, which is concerning because stock prices follow EPS over the long term
Macy’s stock price of $25.06 implies a valuation ratio of 10.5x forward P/E. Dive into our free research report to see why there are better opportunities than M.
Clorox (CLX)
Consensus Price Target: $105.29 (7.4% implied return)
Founded in 1913 with bleach as the sole product offering, Clorox (NYSE:CLX) today is a consumer products giant whose product portfolio spans everything from bleach to skincare to salad dressing to kitty litter.
Why Is CLX Not Exciting?
-
Annual sales declines of 1.9% for the past three years show its products struggled to connect with the market
-
Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
-
Free cash flow margin dropped by 5.8 percentage points over the last year, implying the company became more capital intensive as competition picked up
Clorox is trading at $98.03 per share, or 16.4x forward P/E. Read our free research report to see why you should think twice about including CLX in your portfolio, it’s free.
One Stock to Watch:
Keurig Dr Pepper (KDP)
Consensus Price Target: $33.25 (6% implied return)
Born out of a 2018 merger between Keurig Green Mountain and Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ:KDP) is a consumer staples powerhouse boasting a portfolio of beverages including sodas, coffees, and juices.
Leave a comment